PMID- 28442532 OWN - NLM STAT- MEDLINE DCOM- 20180423 LR - 20180521 IS - 1708-8267 (Electronic) IS - 1081-5589 (Linking) VI - 65 IP - 6 DP - 2017 Aug TI - Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi. PG - 999-1007 LID - 10.1136/jim-2017-000442 [doi] AB - Deep venous thrombosis (DVT) is a common vascular disease and is closely linked to inflammation. Over the past decade, the potential antithrombotic effect of statins has been elucidated by clinical studies, primarily through focusing on DVT prevention. The effects of statins on DVT resolution and its underlying mechanisms have been rarely addressed. We established a rabbit model of the inferior vena cava (IVC) venous thrombosis. After 48 hours, the rabbits were treated with saline, heparin, simvastatin, or simvastatin combined with heparin, respectively, for 14 days. The migration of inflammatory cells (neutrophils, monocytes, lymphocytes) in the thrombi and injured venous wall, the plasma levels of interleukin (IL)-6, monocyte chemotactic protein 1 (MCP-1) and P-selectin, and local expression of MCP-1 and P-selectin in the venous wall were evaluated by histology, immunohistochemistry, and ELISA examinations. Our data showed that compared with saline and heparin controls, monotherapy of simvastatin and the adjunctive therapy with simvastatin and heparin significantly improved the thrombus resolution and reduced inflammatory cells migration into the venous wall, the release of the inflammatory cell adhesion molecule (P-selectin), inflammatory chemokine (MCP-1) and pleiotropic proinflammatory cytokines (IL-6) into the blood, and the local expression of P-selectin and MCP-1 in the venous wall. Simvastatin targets anti-inflammatory pathways during the resolution phase of a thrombus, providing a therapeutic potential in DVT resolution and post-thrombotic syndrome prevention. CI - Copyright (c) 2017 American Federation for Medical Research. FAU - Feng, Yaping AU - Feng Y AD - Department of Vascular Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. FAU - Lei, Bo AU - Lei B AD - Anesthesia Department, Beijing Haidian Maternal & Child Health Hospital, Beijing, China. FAU - Zhang, Fuxian AU - Zhang F AD - Department of Vascular Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. FAU - Niu, Luyuan AU - Niu L AD - Department of Vascular Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. FAU - Zhang, Huan AU - Zhang H AD - Department of Vascular Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. FAU - Zhang, Mingyi AU - Zhang M AD - Department of Vascular Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. LA - eng PT - Journal Article DEP - 20170425 PL - England TA - J Investig Med JT - Journal of investigative medicine : the official publication of the American Federation for Clinical Research JID - 9501229 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Cytokines) RN - 0 (Lipids) RN - AGG2FN16EV (Simvastatin) SB - IM CIN - J Investig Med. 2018 Feb;66(2):e3. PMID: 29018049 MH - Animals MH - Anti-Inflammatory Agents/pharmacology/*therapeutic use MH - Cell Movement/drug effects MH - Cytokines/blood MH - Inflammation/pathology MH - Lipids/blood MH - Male MH - Rabbits MH - Simvastatin/pharmacology/*therapeutic use MH - Venous Thrombosis/blood/*drug therapy/pathology OTO - NOTNLM OT - Vascular Diseases COIS- Competing interests: None declared. EDAT- 2017/04/27 06:00 MHDA- 2018/04/24 06:00 CRDT- 2017/04/27 06:00 PHST- 2017/03/25 00:00 [accepted] PHST- 2017/04/27 06:00 [pubmed] PHST- 2018/04/24 06:00 [medline] PHST- 2017/04/27 06:00 [entrez] AID - jim-2017-000442 [pii] AID - 10.1136/jim-2017-000442 [doi] PST - ppublish SO - J Investig Med. 2017 Aug;65(6):999-1007. doi: 10.1136/jim-2017-000442. Epub 2017 Apr 25.